PAK4 as a cancer immune-evasion target
- PMID: 35121838
- DOI: 10.1038/s43018-019-0012-z
PAK4 as a cancer immune-evasion target
Comment on
-
PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer. 2020;1(1):46-58. doi: 10.1038/s43018-019-0003-0. Epub 2019 Dec 9. Nat Cancer. 2020. PMID: 34368780 Free PMC article.
References
-
- Tumeh, P. C. et al. Nature 515, 568–571 (2014). - DOI
-
- Ayers, M. et al. J. Clin. Invest. 127, 2930–2940 (2017). - DOI
-
- Ribas, A. Cancer Discov. 5, 915–919 (2015). - DOI
-
- Gajewski, T. F. et al. Curr. Opin. Immunol. 25, 268–276 (2013). - DOI
-
- Spranger, S. & Gajewski, T. F. Nat. Rev. Cancer 18, 139–147 (2018). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials